Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2328-2329

  Alvarez M L ^a   Errasti, P ^a   Gomez G ^a   Lavilla, F J ^a   Garcia N ^a   Ballester, B ^a   Garcia I ^a   Purroy, A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PYRROLES; TIME FACTORS; TRIGLYCERIDES;

EID: 0032855167     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00363-2     Document Type: Conference Paper

References (4)

1. Massy Z.A., Kasiske B.L. Curr Opin Nephrol Hypertens. 5:1996;141.
2. Kasiske B.L., Guijarro C., Massy Z.A., et al. J Am Soc Nephrol. 7:1996;158.
3. Kobashigawa J.A., Kasiske B.L. Transplantation. 63:1997;331.
4. Arnadottir M., Berg A.L. Transplantation. 63:1997;339.